Trials / Completed
CompletedNCT00168480
A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 424 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a three year open-label study in subjects with axillary hyperhidrosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Botulinum Toxin Type A | 100 U, repeated treatments at \> 4 month intervals up to Month 32, over a 36-month study period |
Timeline
- Start date
- 2003-11-01
- Primary completion
- 2007-04-01
- Completion
- 2007-04-01
- First posted
- 2005-09-15
- Last updated
- 2008-09-29
Locations
4 sites across 4 countries: United States, Germany, Sweden, United Kingdom
Source: ClinicalTrials.gov record NCT00168480. Inclusion in this directory is not an endorsement.